Zobrazeno 1 - 10 of 32 pro vyhledávání: '"Elisa Attkisson"'
1
Data from Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo
Autor: Steven Grant, Jonathan W. Friedberg, Richard I. Fisher, Paul Dent, Elisa Attkisson, Minkyeong P. Son, Dmitry Lembersky, Girija Dasmahapatra
Interactions between the proteasome inhibitor carfilzomib and the histone deacetylase (HDAC) inhibitors vorinostat and SNDX-275 were examined in mantle cell lymphoma (MCL) cells in vitro and in vivo. Coadministration of very low, marginally toxic car
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2be1be7416a017d1b9dc7f07a91f751
https://doi.org/10.1158/1535-7163.c.6535273.v1
Zobrazit plný text záznamu
2
Data from Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo
Autor: Steven Grant, Paul Dent, Jonathan W. Friedberg, Richard I. Fisher, Elisa Attkisson, Derick Peterson, Hiral Patel, Minkyeong P. Son, Dmitry Lembersky, Girija Dasmahapatra
Interactions between the irreversible proteasome inhibitor carfilzomib and the pan-BH3 mimetic obatoclax were examined in germinal center (GC)- and activated B-cell–diffuse large B-cell lymphoma (ABC-DLBCL) cells. Cotreatment with minimally toxic c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f35e4dce90a90513f607ad8d5705bab
https://doi.org/10.1158/1535-7163.c.6535501
Zobrazit plný text záznamu
7
Supplementary Figure 2 from PLK1 Inhibitors Synergistically Potentiate HDAC Inhibitor Lethality in Imatinib Mesylate–Sensitive or –Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
Autor: Steven Grant, Elisa Attkisson, Tri Nguyen, Hiral Patel, Girija Dasmahapatra
PDF file - 90K, Various PLK1 and HDAC inhibitors interact synergistically in CML models including those sensitive or resistant to IM. A. LAMA84 cells were treated with BI2536 (2.0 nM) � vorinostat (1.0 �M) for 48 hr. B. K562 cells were treated wi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9679ca3e0a76d55f323fbd0454d0a178
https://doi.org/10.1158/1078-0432.22455911
Zobrazit plný text záznamu
10
Supplementary Figure 5 from PLK1 Inhibitors Synergistically Potentiate HDAC Inhibitor Lethality in Imatinib Mesylate–Sensitive or –Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
Autor: Steven Grant, Elisa Attkisson, Tri Nguyen, Hiral Patel, Girija Dasmahapatra
PDF file - 290K, Co-treatment with BI2536 and vorinostat induces regression in flank tumors (K562 cells) and increases the survival of mice with systemic tumors. Tumor size was monitored at the end of (A) 14 days of drug (BI2536 + vorinostat) treatme
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfac281cc80e6bd2a22add1617d9ece
https://doi.org/10.1158/1078-0432.22455902
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje